12.1 Common adverse effects |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.1.1 Hospitalization |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.1.2 Fatal myocardial infarction |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.1.3 Cutaneous toxicity from electron beam therapy |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.1.4 Acute non‐lymphocytic leukaemia |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.1.5 Non‐melanoma skin cancer |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.1.6 Unspecified |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
12.2 Complete response |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
12.3 Relapse |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
12.4 Overall survival |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
12.5 Objective response rate |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |